Literature DB >> 28419713

NT-proBNP predicts mortality in adults with transposition of the great arteries late after Mustard or Senning correction.

Jana Rubáčková Popelová1,2, Markéta Tomková1,3, Jakub Tomek1,4.   

Abstract

OBJECTIVE: The patients after Mustard and Senning corrections of transposition of the great arteries (TGA) are at an increased risk of unexpected death. The aim of this study was to identify markers allowing risk stratification of patients after atrial switch correction of TGA to provide them with optimum care. METHODS AND
RESULTS: In this study, 87 patients were retrospectively evaluated after atrial switch correction of TGA followed-up between 2005 and 2015. The mortality during the follow-up was 9% (8 cardiac deaths). Markers significantly predictive of death using univariable Cox proportional hazard ratio survival analysis were: N-terminal pro-B-type natriuretic peptide (NT-proBNP), ejection fraction and end-diastolic dimension of the systemic right ventricle, mitral E, e', and s'. Surprisingly, the Doppler parameters of mitral valve in subpulmonary ventricle were more important for prognosis than those of systemic tricuspid valve. In multivariable analysis, the only independent predictors of mortality were NT-proBNP (P = .00048; AUC 0.97) and the velocity of early diastolic filling (mitral E) in subpulmonary ventricle (P = .01815; AUC 0.81). According to Kaplan-Meier survival analysis, patients with NT-proBNP > 1000 pg/ml are at high risk of death. Patients with mitral E < 68 cm/s are also at an increased risk of death.
CONCLUSIONS: NT-proBNP is the most reliable prognostic mortality factor and should be measured regularly in TGA patients after Mustard or Senning correction. Diastolic filling velocity of the subpulmonary left ventricle (mitral E) may be more important for prognosis than systolic function of the systemic right ventricle.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Mustard and Senning operation; NT-proBNP; adult congenital heart disease; mitral E; mortality; transposition of the great arteries

Mesh:

Substances:

Year:  2017        PMID: 28419713     DOI: 10.1111/chd.12466

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  3 in total

1.  Exploring the Prognostic Value of Novel Markers in Adults With a Systemic Right Ventricle.

Authors:  Laurie W Geenen; Roderick W J van Grootel; Korhan Akman; Vivan J M Baggen; Myrthe E Menting; Jannet A Eindhoven; Judith A A E Cuypers; Eric Boersma; Annemien E van den Bosch; Jolien W Roos-Hesselink
Journal:  J Am Heart Assoc       Date:  2019-08-21       Impact factor: 5.501

2.  Sacubitril/valsartan in the treatment of systemic right ventricular failure.

Authors:  Tjitske E Zandstra; Marieke Nederend; Monique R M Jongbloed; Philippine Kiès; Hubert W Vliegen; Berto J Bouma; Laurens F Tops; Martin J Schalij; Anastasia D Egorova
Journal:  Heart       Date:  2021-01-15       Impact factor: 7.365

3.  Systematic Evaluation of Systemic Right Ventricular Function.

Authors:  Matthias Schneider; Matthias Beichl; Christian Nietsche; Dietrich Beitzke; Gerold Porenta; Gilbert Beran; Karin Vonbank; Jakob Hauser; Christian Hengstenberg; Georg Goliasch; Thomas Binder; Harald Gabriel
Journal:  J Clin Med       Date:  2019-12-31       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.